In a comprehensive pan-cancer analysis, high PTX3 RNA expression was similarly associated with worse survival across various malignant tumors, leading the authors to propose PTX3 as a potential pan-cancer prognostic marker [24]. The gene discussed is PTX3; the disease is cancer.